Hogs Leak Lower on Thursday
Lean hog futures ended the back and forth Thursday session with contracts down 7 to 95 cents in the nearbys. The USDA national average base hog negotiated price was down $1.21 from the day prior at $87.67 in the Thursday PM report. CME's Lean Hog Index from April 1 was up 15 from the previous day on at $88.80.
Wednesday's 'Liberation Day' tariffs came with Mexico and Canada left off the list and the exemption on all USMCA compliant goods remaining in place. Reciprocal tariffs were put in place on Japan at 24%, South Korea at 25% and China at 34% (54% including the initial set of tariffs from earlier this year). They go into effect on April 9.
Pork export sales totaled 52,953 MT in the week that ended on March 27, the largest so far this MY. Mexico was the buyer of 30,600 MT, with 10,300 MT to China. Export shipments came in at 32,899 MT, which was a 3-week high. Of that total, 12,200 MT was headed to Mexico, with 5,200 MT to South Korea.
Census trade data was released this morning, with a converted carcass basis total of 565.2 million lbs of pork exported in February. That was a 2% decline from January and down 4.8% from last year.
USDA's pork cutout value from Thursday afternoon was up $1.11 at $94.81 per cwt. The belly, picnic and rib primals were reported lower, with the loin leading the charge higher, up $7.04. USDA estimated the Thursday Federally inspected hog slaughter at 488,000 head, with a weekly total at 1.926 million head. That is down 13,000 head from last week but 106,548 head above the same week last year.
Apr 25 Hogs closed at $87.375, down $0.075,
May 25 Hogs closed at $88.575, down $0.550
Jun 25 Hogs closed at $95.550, down $0.975,
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada Standard
12 hours ago
- Canada Standard
Australian PM says not to compromise biosecurity laws in tariff negotiations with U.S.
CANBERRA, June 6 (Xinhua) -- Australian Prime Minister Anthony Albanese said on Friday that his government will not loosen biosecurity laws as it considers lifting a restriction on imports of U.S. beef. The Australian Broadcasting Corporation (ABC) and Nine Entertainment newspapers reported on Friday that Albanese's Labor Party government could use the import ban on some beef slaughtered in the U.S. as a bargaining chip in negotiations for an exemption from U.S. tariffs. Responding to the reports, Albanese said that his government would not negotiate on biosecurity but would be open to a solution that would not compromise food safety. "We'll never loosen any rules regarding our biosecurity," he told ABC radio. Australia lifted a blanket ban on U.S. beef imports, which had been in place since 2003, in 2019 but import restrictions on beef products from Canadian and Mexican cattle slaughtered in the U.S. remain in place. The U.S. administration in March identified biosecurity laws relating to beef imports as a trade grievance with Australia ahead of unveiling the 'Liberation Day' tariffs. The ABC and Nine Entertainment both reported that Australian officials believe that biosecurity laws could be tweaked to allow U.S. beef into Australia without risking safety. It comes ahead of an expected meeting between Albanese and U.S. President Donald Trump on the sidelines of the upcoming G7 Leaders' Summit in Canada. Health Minister Mark Butler, a member of Albanese's cabinet, told Seven Network television on Friday that the beef import restrictions have been under review for "some time." "This will be a decision taken on its merits, not for convenience, not to get a deal. We'll be taking a decision in the national interest in this area," he said. Albanese told ABC radio that he is looking forward to having a face-to-face meeting with Trump and again described the U.S. tariffs as an act of economic "self-harm."
The Market Online
a day ago
- The Market Online
Buzz on the Bullboards: Aviation, cannabis, and industrial stocks undeterred by tariff drama
Any momentum the TSX would have gathered this week quickly eroded by escalating global trade tensions. The index opened the week on a positive note, buoyed by rising energy and materials stocks, reflecting investor optimism around strong commodity prices and a rebound in global demand. However, sentiment quickly shifted midweek following U.S. President Donald Trump's announcement to double tariffs on imported steel and aluminum—from 25 per cent to 50 per cent. The move, part of his so-called 'Liberation Day' trade strategy, rattled markets and reignited fears of a broader trade war. The tariffs, set to take effect in early July, will apply to all countries except the United Kingdom, which recently reached a preliminary trade agreement with Washington. There is a lot going on to keep track of, though this is considered a time where activity seasonally slows down. Even so, users have wasted little time in searching for things to get riled up about. I'll take 'Things that never happened' for $100. Meanwhile, the Bank of Canada held its benchmark interest rate steady at 2.75 per cent, the second consecutive rate hold following a series of seven cuts, citing tariff uncertainty as a reason to be cautious. This stance shows the strength and diversity of Canadian equities, particularly in sectors like pharmaceuticals, aerospace, and advanced manufacturing. MediPharm Labs (TSX:LABS, Forum), a pharmaceutical business in precision-based cannabinoids, has announced the commencement of production for its novel cannabis metered dose inhalers (MDIs) aimed at the European Union and United Kingdom markets. These discreet, smoke-free devices offer patients a fast-acting, pharmaceutical-grade alternative to traditional cannabis consumption methods. What the 'Buzz' Our Bullboards have up to 2 million pageviews a day. Get the inside scoop on conversations around the most significant trends and stock appreciations in our weekly wrap up. Get 'Buzz on the Bullboards' delivered to your inbox every third Thursday! Buzz on the Bullboards | Sign Up Here Manufactured under stringent Good Manufacturing Practices (GMP), the MDIs are distributed exclusively by Blackpoint Ltd., MediPharm's regional partner. The company has already launched the product in Canada and anticipates further rollouts in Australia, the EU, and the UK by Q3 2025. This expansion comes on the heels of a $4.5 million cash sale of its Hope facility, a move aimed at streamlining operations. However, internal turbulence looms. A proxy battle with dissident shareholder Apollo Technology Capital Corp. has raised concerns about governance and financial stability. Despite these headwinds, MediPharm reported an 11 per cent revenue increase in Q1, signaling operational momentum amid strategic uncertainty. MediPharm published a response, calling Apollo Capital 'dissidents' and they 'do not believe they are the well-intentioned and successful business leaders they portray themselves to be', saying the company is currently 'under attack'. Even so, MediPharm stock has risen more than 7 per cent in the past five days. Bombardier (TSX:BBD, Forum) has reached a major milestone in its Global 8000 program, with the first production aircraft completing its inaugural flight on May 16. Departing from the company's Aircraft Assembly Centre in Mississauga, Ontario, the flight marks a pivotal step toward the aircraft's entry into service in the second half of 2025. The Global 8000 is positioned as the next evolution of the Global 7500, offering a top speed of Mach 0.94 and an industry-leading range of 8,000 nautical miles. It's designed to connect global cities like Singapore to Los Angeles and London to Perth without refueling, while also offering access to shorter runways typically reserved for smaller jets. Inside, the aircraft redefines luxury with four true living spaces, a dedicated crew rest area, and the lowest cabin altitude in its class. With over 250,000 flight hours logged by the Global 7500, Bombardier's latest innovation is poised to capture a significant share of the ultra-long-range business jet market. Bombardier stock has lifted nearly 2 per cent in the past five days. Advanced materials innovator PyroGenesis (TSX:PYR, Forum) has secured a major endorsement from aerospace giant Boeing (NYSE:BA, Forum). The company's Ti64 'coarse' metal powder—used in additive manufacturing—has been officially approved and added to Boeing's qualified supplier list. This qualification is a significant validation of PyroGenesis' proprietary plasma atomization technology, which produces high-purity metal powders for 3D printing in aerospace and defense applications. The approval opens the door to broader adoption of PyroGenesis' materials in Boeing's manufacturing ecosystem, potentially unlocking new revenue streams and long-term contracts. In the past five days, PyroGenesis stock has climbed nearly 2 per cent. As the aerospace industry increasingly turns to additive manufacturing for lightweight, high-performance components, PyroGenesis is well-positioned to benefit from this structural shift. These three TSX-listed companies—MediPharm Labs, Bombardier, and PyroGenesis—are each making headlines for different reasons, from product innovation and international expansion to strategic partnerships and shareholder activism. While the TSX continues to climb, investors would be wise to dig deeper into these stories, assess the risks and opportunities, and consider how these developments align with their investment goals. As always, thorough due diligence remains the cornerstone of smart investing. For previous editions of Buzz on the Bullboards, click here. Join the discussion: Find out what everybody's saying about these stock on Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
The Market Online
2 days ago
- The Market Online
@ the Bell: Tariff talks stall market movement
Led by energy sector losses, Canada's top stock index remained slid on Wednesday, as investors looked ahead to potential tariff discussions between the United States and its global trade partners. From Our Partners The US government had set Wednesday as the deadline for its trading partners to present trade proposals to avoid the so-called 'Liberation Day' tariffs, which are scheduled to take effect in early July. On the same day, Washington announced it would double tariffs on steel and aluminum imports, applying the increase to all countries except the United Kingdom, which is the only nation to have reached a preliminary trade agreement. The US and China are expected to hold talks later this week aimed at resolving ongoing trade disputes. Meanwhile, the Bank of Canada held its benchmark interest rate steady at 2.75 per cent, the second consecutive rate hold following a series of seven cuts, citing tariff uncertainty as a reason to be cautious. The Canadian dollar traded for 73.11 cents US compared to 72.89 cents US on Tuesday. US crude futures traded $0.61 lower at US$62.80 a barrel, and the Brent contract lost $0.75 to US$64.88 a barrel. The price of gold was up US$20.09 to US$3,373.31. In world markets, the Nikkei was up 300.64 points to ¥37,747.45, the Hang Seng was up 141.54 points to HK$23,654.03 the FTSE was up 14.27 points to ₤8,801.29, and the DAX was up 184.86 points to €24,276.48. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
